Home › Chronic Progressive Multiple Sclerosis › New York
Chronic Progressive Multiple Sclerosis clinical trials in New York
4 studies for Chronic Progressive Multiple Sclerosis are looking for participants at sites in New York.
Cities in New York
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
- Mount Sinai Medical Center, New York
RecruitingPhase 3
Ages 18 to 60 · All sexes · Updated Nov 12, 2026 · NCT07299019A Phase 2a Study of SUN-627 in Participants With Non-Active Secondary Progressive and Primary Progressive Multiple Sclerosis (SPMS/PPMS)
- Local Institution - Site 106, Stony Brook
RecruitingPhase 2
Ages 18 to 70 · All sexes · Updated Oct 30, 2026 · NCT07840326Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
- Corinne Goldsmith Dickinson Center for Multiple Sclerosis at Mount Siinai, New York
- Rochester Multiple Sclerosis Center, University of Rochester, Rochester
RecruitingPhase 3
Ages 18 to 55 · All sexes · Updated Oct 20, 2026 · NCT04047628Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis
- Mt. Sinai, New York
RecruitingPhase 1/2
Ages 18 to 65 · All sexes · Updated Sep 21, 2026 · NCT07477639From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.